In 2022, Drexel University’s C. & J. Nyheim Plasma Institute (NPI) is celebrating 20 years not only as a multidisciplinary research and educational institute at the University, but as a flagship ...

Plasma, the fourth state of matter, is an ionized gas containing positive and negative ions or electrons. Nowadays various types of plasmas are used in different applications, from welding and vehicle ...

Dear colleague, On behalf of the International Society for Plasma Medicine (ISPM), we are delighted to invite you to the 6th International Conference on Plasma Medicine (ICPM-6), which will be held in ...

Researchers have developed cold plasma-activated Ringer’s solution for chemotherapy. The solution has anti-tumor effects in vitro and in vivo that derive from the lactate component. Nagoya University ...

As interest in the application of plasma medicine -- the use of low-temperature plasma (LTP) created by an electrical discharge to address medical problems -- continues to grow, so does the need for ...

Exploring the possibilities of atmospheric-pressure plasmas to develop and consolidate new medical therapies is the main objective of the PlasTHER network, an initiative funded by the European Union ...

RESEARCH TRIANGLE PARK – Grifols, a global leader in plasma medicines, on Monday announced it has received approval from the U.S. Food and Drug Administration (FDA) for its new immunoglobulin (Ig) ...

Ottawa, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The global plasma derived medicine market size was valued at USD 17.24 billion in 2024 and is predicted to hit around USD 37.4 billion by 2034, a study ...

The MOU was signed by Saeed Sarkar, an official with the Vice-Presidency for Science and Technology, Shahin Akhoundzadeh, an official with the Ministry of Health, and Mahdiyeh Bakhtiari, the CEO of ...

It is a bit ironic that plasma is the least known state of matter, when in fact it is the most abundant in the universe. It is found in our Sun and all other stars, lightning, in our TVs, fluorescent ...

BARCELONA, Spain, April 18, 2024 (GLOBE NEWSWIRE) -- Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, today officially ...